Thus, FTO may inhibit ICC progression by reducing oncogene expression (TEAD2 and CMTM4) and inducing tumor suppressor expression (HAO2, NR5A2, CCL19, TCF21, NTRK2, and SCML4). Here, SCML4 is linked to intrahepatic cholangiocarcinoma.